Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1977-05-10
1978-06-13
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 260112R, 424 12, 424251, 544264, G01N 3316, A61K 4300, C07G 700, A61K 3900
Patent
active
040949648
ABSTRACT:
A sensitive immunoassay for clonidine, 2-(2,6-dichloroanilino)-2-imidazoline hydrochloride is described. To prepare the clonidine selective antiserum, an antigen is made comprising 4-[[6-[2,4-dichloro-3(4,5-dihydro-1H-imidazol-2-yl)amino]hydroxyphenyl]azo ]benzoic acid covalently bonded to an immunogenic carrier material through a peptide bond formed from said carboxyl group and amino groups contained in said immunogenic carrier material and the antigen is injected into a suitable host animal to elicit the desired antiserum.
REFERENCES:
frydman, Chemical Abstracts, vol. 84, No. 9, Mar. 1, 1976, p. 5, Abstract No. 53715c.
Rouot et al., Chemical Abstracts, vol. 85, No. 9, Aug. 30, 1976, p. 17, Abstract No. 56532x.
Jarrott Bevyn
Spector Sidney
Gould George M.
Hoffmann-La Roche Inc.
Nucker Christine M.
Padgett Benjamin R.
Welt Samuel L.
LandOfFree
Clonidine assay does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Clonidine assay, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Clonidine assay will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-10135